l-Ornithine l-Aspartate (LOLA) for Hepatic Encephalopathy in Cirrhosis: Results of Randomized Controlled Trials and Meta-Analyses

This manuscript represents an appraisal of the evidence in support of l-ornithine-l-aspartate (LOLA) for the management and treatment of hepatic encephalopathy (HE) in cirrhosis. Meta-analyses of randomized controlled trials (RCTs) conducted over the last two decades generally reveal evidence of ben...

Descripción completa

Detalles Bibliográficos
Autores principales: Butterworth, Roger F., McPhail, Mark J. W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6416237/
https://www.ncbi.nlm.nih.gov/pubmed/30706425
http://dx.doi.org/10.1007/s40265-018-1024-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6416237/
https://www.ncbi.nlm.nih.gov/pubmed/30706425
http://dx.doi.org/10.1007/s40265-018-1024-1

Ejemplares similares